Pharmacologic treatment of hypercholesterolemia falls short of U.S. and European guidelines, according to a study published online June 30 in the Journal of General Internal Medicine. G. Caleb ...

Adrenal adenomas were associated with attenuated weight loss among patients with obesity or overweight using GLP-1 or GIP/GLP-1 RAs.

Patients with overweight or obesity and heart failure with preserved ejection fraction that have unintentional weight loss have worse outcomes.